<DOC>
	<DOCNO>NCT00219128</DOCNO>
	<brief_summary>Evaluate blood pressure lower effect aliskiren 150mg , 300mg 600mg compare placebo patient essential hypertension</brief_summary>
	<brief_title>A Dose Ranging Study Compare Safety Efficacy Aliskiren 150mg , 300mg , 600mg Placebo Patients With High Blood Pressure .</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Inclusion Criteria Patients essential hypertension Patients eligible able participate study Exclusion Criteria Severe hypertension History evidence secondary form hypertension History Hypertensive encephalopathy cerebrovascular accident . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Hypertension , aliskiren , blood pressure , placebo</keyword>
</DOC>